extraperitoneoscopic radical prostatectomy after pelvic sugery procedures.

Area of Science:

• Urology
• Surgical Oncology

Background:

• Prostate cancer treatment often involves radical prostatectomy.
• Minimally invasive techniques aim to reduce morbidity.
• Extraperitoneoscopic radical prostatectomy (ERPE) offers a less invasive approach.

Purpose of the Study:

• To evaluate the outcomes of extraperitoneoscopic radical prostatectomy (ERPE).
• To assess ERPE efficacy in patients with complicating factors, including prior prostate procedures.

Main Methods:

• A prospective study included 7 patients with prostate cancer (T1-T2b, No, Mo) undergoing ERPE.
• Surgical duration, blood loss, and complication rates were recorded.
• Postoperative outcomes, including urinary function, sexual potency, and PSA levels, were monitored.

Main Results:

• ERPE duration ranged from 3 hours 40 minutes to 6 hours 30 minutes with minimal blood loss (350±20 ml).
• Complications occurred in 28.57% of patients, with 85.71% experiencing temporary urinary retention.
• 100% reported absent sexual potency post-surgery; 14.29% had mild incontinence.

Conclusions:

• Extraperitoneoscopic radical prostatectomy (ERPE) demonstrates effectiveness and safety, even in patients with a history of transurethral prostate surgery.
• Further extensive studies with larger patient cohorts are necessary to confirm these findings.